From Financial Modeling Prep: 2025-04-03 12:56:00

UBS maintains a Buy rating for CME Group with a $290 price target, citing strong trading activity and favorable macro conditions. Revised first-quarter 2025 EPS forecast to $2.78, above Wall Street’s $2.62 consensus, driven by higher futures volumes in equities and interest rate products. Pricing assumptions adjusted slightly lower, but UBS expects support from equity income and increased interest income. Market volatility seen as potential catalyst for greater trading volumes. Shares up around 3% intra-day.



Read more at Financial Modeling Prep:: UBS Sticks to Bullish View on CME Group, Shares Up…